---
title: "300896.SZ (300896.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300896.SZ/news.md"
symbol: "300896.SZ"
name: "300896.SZ"
parent: "https://longbridge.com/en/quote/300896.SZ.md"
datetime: "2026-05-20T04:35:06.552Z"
locales:
  - [en](https://longbridge.com/en/quote/300896.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300896.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300896.SZ/news.md)
---

# 300896.SZ (300896.SZ) — Related News

### [Securities Times published an article: Beware of thousand-yuan stocks "It's lonely at the top"](https://longbridge.com/en/news/286169483.md)
*2026-05-12T23:42:30.000Z*
> The Securities Times pointed out that the number of stocks priced at a thousand yuan in the A-share market is gradually 

### [Tax Evasion "Standardized Process" Behind: The Era of Strong Regulatory Supervision in the Medical Aesthetics Industry Has Arrived](https://longbridge.com/en/news/285375221.md)
*2026-05-06T12:06:10.000Z*
> In recent years, tax authorities have strengthened their supervision of the medical beauty industry, severely cracking d

### [IMEIK's first-quarter revenue is 630 million: net profit of 300 million, a year-on-year decrease of 33%, Yuan Feng reduces holdings, cashing out over 100 million](https://longbridge.com/en/news/283672159.md)
*2026-04-22T13:05:33.000Z*
> IMEIK released its Q1 2026 financial report, with revenue of 634 million yuan, a year-on-year decrease of 4.48%; net pro

### [Is it hard to earn women's money? The "Hyaluronic Acid Queen" has seen her market value evaporate by 100 billion, and the medical beauty industry is undergoing a major reshuffle](https://longbridge.com/en/news/283437223.md)
*2026-04-21T04:07:33.000Z*
> The market values of "Hyaluronic Acid Queen" IMEIK and Bloomage Biotech have significantly evaporated. The former's stoc

### [Revenue and net profit both decline, core product growth slows down, IMEIK's high growth "comes to an end"](https://longbridge.com/en/news/282971218.md)
*2026-04-16T09:12:19.000Z*
> IMEIK faces a double decline in performance in 2025, with revenue decreasing by approximately 19% year-on-year and net p

### [IMEIK: The holding subsidiary has obtained the medical device registration certificate for the radiofrequency skin treatment device](https://longbridge.com/en/news/280997948.md)
*2026-03-30T10:18:15.000Z*
> Sina Finance reported on March 30 that IMEIK announced that its holding subsidiary, Shanghai Weimai Medical Technology C

### [CITIC Securities: Maintain IMEIK "Buy" rating, with internal + external growth driving long-term momentum](https://longbridge.com/en/news/280585677.md)
*2026-03-26T07:47:17.000Z*
> CITIC Securities maintains a "Buy" rating on IMEIK, pointing out that the company's performance is facing temporary pres

### [For the first time since its listing, both annual revenue and net profit of "medical beauty leader" IMEIK have declined. Where does the pressure come from?](https://longbridge.com/en/news/280425410.md)
*2026-03-25T06:49:49.000Z*
> IMEIK released its first annual report since going public in 2025, showing a decline in both revenue and net profit. Ope